JAK kinase inhibitors can inhibit the activation and differentiation of CD4 + T cells [11]; reduce the number of Th1, Th17, and regulatory T cells (Tregs); inhibit the activation and maturation of NK cells; and easily cause immunosuppression, thus increasing the risk of infection [12]. The gene discussed is CD4; the disease is infection.